Dexrazoxane Hydrochloride in Preventing Heart-Related Side Effects of Chemotherapy in Participants With Blood Cancers

NCT03589729 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
Blasts 10 Percent or More of Bone Marrow Nucleated Cells
High Risk Myelodysplastic Syndrome
Myeloid Sarcoma
Myeloproliferative Neoplasm
Philadelphia Chromosome Positive

Interventions

DRUG: Cladribine
DRUG: Cytarabine
DRUG: Dexrazoxane Hydrochloride
DRUG: Gemtuzumab Ozogamicin
DRUG: Idarubicin

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]